Blair Robertson

Blair Robertson currently serves as the Senior Vice President and Integrated Product Team Lead for Neuromuscular at Asklepios BioPharmaceutical, Inc. since March 2024. Previously, Blair held the position of Global Program Team Lead for Neuroscience at Jazz Pharmaceuticals from October 2021 to March 2024, and served as Vice President and Head of Asset and Commercial Strategy at UCB between February 2019 and October 2021. Earlier roles include Vice President and Head of Franchise Operations for Global Rare Diseases at Sanofi Genzyme, Senior Director of Global Dupilumab Marketing, and Senior Director of Global Marketing for Blood Disorders at Baxalta. Blair's experience also encompasses leadership positions in marketing and strategic roles at Cambridge BioMarketing, Cambrooke Therapeutics, Shire HGT, Bayer Healthcare, and Abbott. Academic credentials include a Doctorate in Molecular Biophysics from the University of Oxford, a First Class Honours Bachelor of Science in Physiology from the University of Otago, and an MBA in Business Administration from the University of New Haven.